Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peifu Jiao

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Molecules (Basel, Switzerland)|January 23, 2024
Anti-PD-L1-Based Bispecific Antibodies Targeting Co-Inhibitory and Co-Stimulatory Molecules for Cancer ImmunotherapyQiaohong Geng, Peifu Jiao
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 23, 2012
Accelerating the multifunctionalization of therapeutic nanoparticles by using a multicomponent reactionHongyu Zhou, Gaoxing Su, Peifu Jiao, et al.
Journal of Fluorescence|June 11, 2013
Synthesis, physical properties and cytotoxicity of stilbene-triazine derivatives containing amino acid groups as fluorescent whitening agentsMaosheng Wan, Shaoli Zhou, Peifu Jiao, et al.
Journal of the American Chemical Society|December 25, 2010
Enhancing cell recognition by scrutinizing cell surfaces with a nanoparticle arrayHongyu Zhou, Peifu Jiao, Lei Yang, et al.
International Journal of Oncology|November 4, 2009
Novel 8-hydroxylquinoline analogs induce copper-dependent proteasome inhibition and cell death in human breast cancer cellsVesna Milacic, Peifu Jiao, Bin Zhang, et al.
Current Pharmaceutical Design|October 7, 2017
PD-1/PD-L1 Inhibitors for Immuno-oncology: From Antibodies to Small MoleculesQiaohong Geng, Peifu Jiao, Peng Jin, et al.
Expert Opinion on Therapeutic Patents|July 28, 2020
Small molecules as antagonists of co-inhibitory pathways for cancer immunotherapy: a patent review (2018-2019)Qiaohong Geng, Sagar O Rohondia, Harras J Khan, et al.
Pharmaceutics|September 28, 2023
Nanomaterial-Based Drug Delivery Systems for Pain Treatment and Relief: From the Delivery of a Single Drug to Co-Delivery of Multiple TherapeuticsYuhang Xu, Xingpeng Dong, Heming Xu, et al.
Current Pharmaceutical Design|November 13, 2018
Small Molecules as PD-1/PD-L1 Pathway Modulators for Cancer ImmunotherapyPeifu Jiao, Qiaohong Geng, Peng Jin, et al.
Journal of Drug Targeting|July 12, 2018
Mesoporous silica-coated gold nanostars with drug payload for combined chemo-photothermal cancer therapyGaoxing Su, Dandan Miao, Yanyan Yu, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Molecules (Basel, Switzerland)|January 23, 2024
Anti-PD-L1-Based Bispecific Antibodies Targeting Co-Inhibitory and Co-Stimulatory Molecules for Cancer ImmunotherapyQiaohong Geng, Peifu Jiao
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 23, 2012
Accelerating the multifunctionalization of therapeutic nanoparticles by using a multicomponent reactionHongyu Zhou, Gaoxing Su, Peifu Jiao, et al.
Journal of Fluorescence|June 11, 2013
Synthesis, physical properties and cytotoxicity of stilbene-triazine derivatives containing amino acid groups as fluorescent whitening agentsMaosheng Wan, Shaoli Zhou, Peifu Jiao, et al.
Journal of the American Chemical Society|December 25, 2010
Enhancing cell recognition by scrutinizing cell surfaces with a nanoparticle arrayHongyu Zhou, Peifu Jiao, Lei Yang, et al.
International Journal of Oncology|November 4, 2009
Novel 8-hydroxylquinoline analogs induce copper-dependent proteasome inhibition and cell death in human breast cancer cellsVesna Milacic, Peifu Jiao, Bin Zhang, et al.
Current Pharmaceutical Design|October 7, 2017
PD-1/PD-L1 Inhibitors for Immuno-oncology: From Antibodies to Small MoleculesQiaohong Geng, Peifu Jiao, Peng Jin, et al.
Expert Opinion on Therapeutic Patents|July 28, 2020
Small molecules as antagonists of co-inhibitory pathways for cancer immunotherapy: a patent review (2018-2019)Qiaohong Geng, Sagar O Rohondia, Harras J Khan, et al.
Pharmaceutics|September 28, 2023
Nanomaterial-Based Drug Delivery Systems for Pain Treatment and Relief: From the Delivery of a Single Drug to Co-Delivery of Multiple TherapeuticsYuhang Xu, Xingpeng Dong, Heming Xu, et al.
Current Pharmaceutical Design|November 13, 2018
Small Molecules as PD-1/PD-L1 Pathway Modulators for Cancer ImmunotherapyPeifu Jiao, Qiaohong Geng, Peng Jin, et al.
Journal of Drug Targeting|July 12, 2018
Mesoporous silica-coated gold nanostars with drug payload for combined chemo-photothermal cancer therapyGaoxing Su, Dandan Miao, Yanyan Yu, et al.
Pageof 2